You are here: Industry Insights > cancer

News List

CT Scan Screen for Lung Cancer Can ID Smoking-Related Diseases drugs
August 28, 2019
Lung cancer screening (LCS) computed tomography (CT) scans can be used to identify smoking-related conditions that frequently are associated with adverse events
Few Oncologists Suggest Health Promotion to Cancer Survivors drugs
August 28, 2019
Few oncologists and specialists recommend health promotion to cancer survivors, according to a study published online in Cancer.
Can Breast Cancer Be a Risk Factor for Opioid Use Among Older Patients? drugs
August 28, 2019
Dealing with breast cancer is tough, and the depression and anxiety that can come with the diagnosis can up the risk of using opioids while lowering survival rates in older women, a new study finds.
XTANDI? treatment granted priority review by FDA europeanpharmaceuticalreview
August 27, 2019
XTANDI? sNDA seeks to add an indication for men with prostate cancer that’s spread but is sensitive to hormone therapy.
Cervical cancer vaccine market set to increase at 12.1 percent CAGR europeanpharmaceuticalreview
August 27, 2019
A recent report has predicted that the cervical cancer vaccine market will increase to $6b by the end of the forecast period.
Risk for Cardiovascular Disease Greater for Childhood Cancer Survivors drugs
August 27, 2019
Survivors of childhood cancer have an increased risk for all subtypes of cardiovascular disease (CVD), according to a research letter published online Aug. 26 in Circulation.
Childhood Cancer Survivors Struggle With Heart Troubles drugs
August 27, 2019
The treatments that childhood cancer patients receive often save their lives, but they also make survivors prone to heart troubles, a new study finds.
Men Should Be Included in Breast Cancer Clinical Trials drugs
August 27, 2019
Men should be included in clinical trials of new breast cancer treatments, the U.S. Food and Drug Administration says.
Imfinzi combination fails advanced lung cancer study europeanpharmaceuticalreview
August 23, 2019
A late-stage clinical trial for Imfinzi and an experimental treatment has not extended the lives of patients with advanced non-small cell lung cancer.
Preventing tumor metastasis worldpharmanews
August 23, 2019
Researchers at the Paul Scherrer Institute, together with colleagues from the pharmaceutical company F. Hoffmann-La Roche AG...